US Stocks
/
ProKidney Corp. Class A Share Price
ProKidney Corp. Class A Share Price

ProKidney Corp. Class A Share Price

NASDAQ: PROK | Micro Cap
$1.59
+$0.01 (0.32%) Last updated on 08 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

ProKidney Corp. Class A Stock Performance

Open
$1.57
Prev. Close
$1.58
Circuit Range
N/A
Day Range
$1.55 - $1.59
Year Range
$1.30 - $3.47
Volume
71,804
Average Traded
$1.57

ProKidney Corp. Class A Share Price Today

As of 8 October 2026, ProKidney Corp. Class A's share price is $1.59. The stock opened at $1.57, compared to its previous close of $1.58. During today's trading session, ProKidney Corp. Class A's share price traded between $1.55 and $1.59, with an average price of $1.57. Over the past 52 weeks, the stock has recorded a high of $3.47 and a low of $1.30. In terms of performance, ProKidney Corp. Class A's share price has declined by 16.32% over the last six months and is down 48.21% on a year-on-year basis.

ProKidney Corp. Class A Share Price Chart

$1.55$1.59
L
Show Current Price
H

ProKidney Corp. Class A Stock Fundamentals & Key Indicators

Market Cap
$212.97M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.40
Revenue (TTM)
$890.00M
Return On Equity (TTM)
9.53%
Profit Margin
-7751.69%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-72.56%

ProKidney Corp. Class A Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.22$0.23$0.23$0.15
Net Profit-$16.47-$19.23-$20.04-$28.42
Net Profit Margin-7486.36%-8360.87%-8713.04%-18946.67%
Income ChangeN/A-16.76%-4.21%-41.82%

ProKidney Corp. Class A Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.08$0.89
Net Profit-$14.40-$35.47-$61.19-$68.99
Net Profit MarginN/AN/A-76487.50%-7751.69%
Income ChangeN/A-146.32%-72.51%-12.75%

About ProKidney Corp. Class A

ProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes. Its product candidate, REACT (Renal Autologous Cell Therapy), is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.

ProKidney Corp. Class A Historical Returns

MonthOpenCloseChange %
Oct 2026
$1.66
$1.57
-4.85%
Sep 2026
$1.86
$1.65
-9.34%
Aug 2026
$1.53
$1.82
+18.95%
Jul 2026
$2.04
$1.53
-24.44%
Jun 2026
$1.82
$2.02
+11.26%
May 2026
$1.90
$1.82
-4.21%
Apr 2026
$1.84
$1.90
+5.85%
Mar 2026
$2.20
$1.79
-20.22%
Feb 2026
$2.01
$2.25
+13.07%
Jan 2026
$2.23
$1.99
-10.76%
Dec 2025
$2.16
$2.23
+0.22%
Nov 2025
$3.10
$2.23
-27.52%

PROK Share Price FAQs

What is ProKidney Corp. Class A share price today?

chevron-up
ProKidney Corp. Class A share price today is $1.59 as on October 8, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of ProKidney Corp. Class A stock?

chevron-up
The 52 week high of ProKidney Corp. Class A stock is $3.47, while the 52 week low is $1.30 as of 8 Oct '26.

What is PROK's market capitalisation today?

chevron-up
PROK market capitalisation is $212.97M as of October 8, 2026, at 4:08 pm IST.

What is PROK's net income for the last quarter?

chevron-up
PROK's net income for the last quarter is -28.42B USD.

What is the 5 year returns of PROK?

chevron-up
The 5 year returns of PROK is -83.97% as on 8 Oct '26.

What is the high & low stock price of PROK today?

chevron-up
PROK stock price hit a high of $1.59 and low of $1.55 as of 8 Oct '26.

Can I buy PROK shares in India?

chevron-up
Yes. You can buy PROK in India by opening an international trading account.